Skip to main content

Latest News

North Innovation Women 2025 List Revealed

The NHSA are shining the spotlight on hundreds of innovative women today - on International Women’s Day - as they publish the annual #NorthInnovationWomen list. You may recognise some familiar faces from the WRIHW and Durham.
Cartoon graphic of a diverse mix of women standing together

Nutrition top tips fort self-management of Persistent pain

What we eat not only impacts our overall health, it can actually affect our pain levels too. So what exactly are the foods we need – and why are they important for pain?

Precision of the Integrated Cognitive Assessment for the assessment of neurocognitive performance in athletes

This study from the Wolfson Research Institute for Health and Wellbeing Concussion Team (Dr Dan Glassbrook, with Professors Paul Chazot and Karen Hind) investigated the precision of the new Integrated Cognitive Assessment (ICA; Cognetivity Neurosciences Ltd., Vancouver, Canada) test for the assessment of information processing ability in athletes.
A model of a human brain from three different angles

Dementia Guide for County Durham published

This new up-to-date guide was developed by the County Durham Dementia Strategy Implementation Group.
Older person looking worried

Study Showcase: Improving Primary Care Services for Imprisoned with Serious Mental Illness (IP-SIS) Study

We do not know whether women with serious mental illness in prison access primary care services. We would like to understand more about this. Hardly any evidence exists about how imprisoned women with SMI use primary care services. These services include general practice, dentists, eye health (opticians) and pharmacists. We want to find out how such services meet their healthcare needs and how these experiences are racially differentiated. This Study is led by WRIHW Fellow Prof Tammi Walker.
Image showing barbed wire fence

Durham University's Girls and Women in the Criminal Justice System Conference

Professor Tammi Walker, Department of Psychology, Durham University is hosting with TEWV Health & Justice Services on February 18th, 2025, the 1st Girls and Women involved with the Criminal Justice System Conference.
Blindfolded woman holding justice scales

International Consortium to Classify Ageing-Related Pathologies (ICCARP) definitions of Senescence

With the global increase in ageing populations, a clear understanding of the physiological and pathological changes associated with ageing is vital for advancing research and clinical practice. Following the World Health Organization’s decision to classify age-related aetiologies, the International Consortium to Classify Ageing-Related Pathologies (ICCARP), including Wolfson Research Institute Fellow, Professor Paul Chazot, was established in 2023.
Cell

New book by Wolfson Fellow - Botanicals for Good Sleep and Dreaming Paperback

Enhance your sleep and dreaming experiences with the transformative power of plants. You may already be familiar with the calming effects of chamomile and lavender for a restful night’s sleep, but there’s much more to discover.
Botanicals Book

People with lived experience of mental health distress will be able to take a lead on health and social care research thanks to new funding

Cumbria, Northumberland, Tyne and Wear NHS Foundation Trust (CNTW), a leading provider of mental health and disability services, has partnered with Durham University, Gateshead Council, Northumbria University and community organisation ReCoCo on a project that aims to redefine the role of lived experience in health research.
Image of Lived Experience Academy

A Message from the Executive Director

I joined you in the Wolfson Institute for Health and Wellbeing last week as the Director – I am delighted to have now started in the role!
Charlotte Clarke smiling

Helping patients to manage chronic pain without strong opioids – a real possibility

Our researchers are changing lives by equipping clinicians and patients with the skills to help manage painful health conditions without using potentially harmful strong opioids.
A hand holding a Live Well With Pain leaflet

MHRA provided scientific advice for the design of the First in Human study plan for Ellorarxine to treat MND

Key Highlights: Ellorarxine, a novel drug compound developed by Nevrargenics, has demonstrated antioxidant and anti-inflammatory effects, which make it a promising new therapy for treating ALS. The results showed that Ellorarxine increases MAP2 expression at low concentrations, induces neurite outgrowth, ameliorates neuroinflammation and modifies GluA2 expression. The MHRA provided scientific advice for the design of the First in Human study and the non-clinical plan.
A computer monitor displaying brain data in fMRI control room.